Ryan B. Gil

Ryan B. Gil is an experienced professional in business development and research within the pharmaceutical and biotechnology sectors. Currently serving as the Director of Business Development at Cambrex since October 2022, Ryan focuses on drug substance custom development and manufacturing services. Prior roles include Senior Business Development Manager at Raybow PharmaScience, where Ryan specialized in green chemistry and customized small molecule synthesis, and Sales Manager at Eurofins BioPharma Services D/A/CH, with responsibilities related to international regulations and the management of key accounts. Ryan's research background includes positions as an Early-stage Researcher at HelmholtzZentrum München, where Ryan worked on diagnostic/prognostic biomarkers using machine learning, and as a Research Associate at the Rowett Institute of Nutrition and Health. Educational qualifications include a PhD in Metabolomics from the Technical University of Munich, an MS in Environmental Analytical Chemistry from the University of Aberdeen, and a degree in Biotechnology from Utah Valley University.